On Monday, Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s shares declined -4.02% to $87.34.
VRX has 66.80% institutional ownership while its EPS ratio was 1.77. The company has 341.19 million shares outstanding while market capitalization of the company was $30.96 billion. Price to book ratio was 4.75. Net profit margin of the company was 6.10% while gross profit margin was 75.00%. Stock volatility for the month was booked as 10.48% while for the week was recorded as 10.64%.
Analysts mean recommendation for the stock is 3.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Valeant Pharmaceuticals International, Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses.
Transocean LTD (NYSE:RIG)’s shares gained 0.43% to $13.97.
RIG has the market capitalization of $5.09 billion. The stock has P/B ratio of 0.37 while EPS was $-1.54. Institutional ownership of the company was 85.40% while 363.74 million shares were outstanding. Net profit margin of the Company was -7.20% while its gross profit margin was 55.30%. Share of the company moved below its SMA 50 with -6.45%. ROE ratio was -4.10% while ROI was -6.40%.
The mean estimate for the short term price target for Transocean LTD (NYSE:RIG) stands at $11.97 according to 27 Analysts. The higher price target estimate for the stock has been calculated at $20.00 while the lower price target estimate is at $4.50
Analysts mean recommendation for the stock is -3.70. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Transocean Ltd. is an international provider of offshore contract drilling services for oil and gas wells. The Company’s primary business is to contract its drilling rigs, related equipment and work crews primarily on a day rate basis to drill oil and gas wells.
At the end of Monday’s trade, Devon Energy Corp (NYSE:DVN)‘s shares dipped -0.71% to $44.93.
So far in 2015, the company has a year-to-date performance of -26.6%. The stock, as of last close, traded 24.77% up from its 52 week low and was -35.62% below its 52 week high. Its latest closing price was -16.66% below the SMA200 while the distance from SMA 50 and SMA 20 was 4.40% and -0.04% respectively.
The mean estimate for the short term price target for Devon Energy Corp (NYSE:DVN) stands at $58.33 according to 30 Analysts. The higher price target estimate for the stock has been calculated at $72.00 while the lower price target estimate is at $43.00.
Analysts mean recommendation for the stock is 2.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Devon Energy Corporation (Devon) is an independent energy company engaged in the exploration, development and production of oil, natural gas and natural gas liquids (NGLs). The Company’s operations are concentrated in various North American onshore areas in the United States and Canada.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.